Cathie Wood's ARK Innovation Stocks Performance Guide: Crispr Therapeutics (CRSP)
CRSP has no dividends
Table and Chart of CRSP Performance
See what a $1,000 investment in CRSP is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRSP Returns | |
|---|---|
| Start Date | Nov-30-2016 |
| Start Price | $21.82 |
| End Date | Nov-28-2023 |
| End Price | $70.66 |
| # Prices | 85 |
| Min Date | May-31-2017 |
| Min Price | $13.62 |
| Max Date | Jan-29-2021 |
| Max Price | $165.70 |
| Total Return | 223.83% |
| Annualized Return | 18.04% |
| Current Value of $1,000 Purchase | $3,238 |
| Number Returns | 3,570 |
| Average Return | 95.57% |
| Number Profitable Returns | 2,496 |
| Percent Profitable Returns | 69.92% |
| Number Unprofitable Returns | 1,074 |
| Percent Unprofitable Returns | 30.08% |
| Profitable to Unprofitable Returns Ratio | 2.32 |
| CRSP Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,636,515,000 | Price to Sales | 253.26 |
| Earnings per Share | $-4.4700 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 2.011 |
| PRICE DATA | |
| 52 Week High | $76.19 |
| 52 Week Low | $37.55 |
| Analyst Target Price | $87.78 |
| 50-Day Moving Average | $48.63 |
| 200-Day Moving Average | $51.95 |
| FINANCIAL DATA | |
| Revenue per Share | $2.155 |
| Revenue | $170,006,000 |
| Profit Margin | -207.9% |
| Return on Equity | -0.192% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRSP Compare Returns with S&P 500
CRSP Trendline Chart